TITLE
ER-positive/HER2-negative and ER-negative/HER2-negative breast cancer biopsies (MDACC/IGR cohort)

SUMMARY
Analysis of pre-treatment biopsies from 103 HER2-normal breast cancer patients (ER-positive and ER-negative subtypes) from MD Anderson Cancer Center/Institut Goustave Russy. Results provide insight into molecular mechanisms associated with chemotherapy sensitivity in breast cancer subtypes.

ORGANISM
Homo sapiens

PLATFORM
GPL96 : [HG-U133A] Affymetrix Human Genome U133A Array

CITATIONS
Iwamoto T, Bianchini G, Booser D, Qi Y et al. Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J Natl Cancer Inst 2011 Feb 2;103(3):264-72. PMID:Â  21191116

